LEARN AT YOUR OWN PACE

The GLP-1 reading room

Practical reading for a more informed conversation with your clinician.

Getting oriented

Your first hour learning about GLP-1

A reading plan for the moment when an unfamiliar treatment becomes a personal question.

Read the guide ↗
Comparison guide

Comparing semaglutide and tirzepatide without losing the context

How to examine two treatment discussions without reducing the choice to a headline or a brand.

Read the guide ↗
Appointment preparation

The questions to settle before joining an online care program

A practical agenda for the conversation between browsing a service and agreeing to its terms.

Read the guide ↗
Money and access

Budgeting for care across the whole commitment

Follow the payment timeline to understand what an advertised monthly price leaves out.

Read the guide ↗
Product identity

Reading a compounded medication offer carefully

What to clarify when a familiar ingredient appears in a compounded product description.

Read the guide ↗
Product identity

Compounded tirzepatide: identify the actual proposal

An ingredient name is the beginning of a product description, not the end of it.

Read the guide ↗
Formulation questions

Compounded semaglutide: questions hidden by a familiar name

How to avoid treating ingredient recognition as complete product knowledge.

Read the guide ↗
Hormone-care research

Estradiol: read the route as well as the name

A hormone-care listing needs its own purpose, product description and clinical discussion.

Read the guide ↗
Hormone-care context

Progesterone: understand its place in the proposed plan

Before comparing an offer, establish the reasoning behind its inclusion.

Read the guide ↗
Local treatment terminology

Vaginal estradiol: why the local product description matters

Use the complete name to keep a specific discussion from becoming a broad hormone comparison.

Read the guide ↗
Wellness claims

NAD+ offerings: test the claim before judging the package

A framework for reading a longevity-labelled service with a more precise set of questions.

Read the guide ↗
Evidence questions

Sermorelin listings: a closer look at the longevity pitch

How to separate an aspirational category from an adequately explained proposal.

Read the guide ↗
Brand-name research

Ozempic in an online offer: familiarity is not a full assessment

Recognising a brand does not establish the prescription, indication or commercial arrangement.

Read the guide ↗
Offer verification

Wegovy pill listings: verify the formulation and availability

Treat an oral-product listing as something to confirm, not proof that a particular service can supply it.

Read the guide ↗
Category explainer

Non-hormonal care: turn a category into a concrete discussion

A broad label cannot tell you which intervention a clinician has in mind.

Read the guide ↗